Skip to main content

Home/ PharmaMics/ Group items tagged #roche

Rss Feed Group items tagged

ramchintamaneni

Roche's Tecentriq: Phase III IMpower110 study at ESMO 2019 - 0 views

  •  
    Roche's Tecentriq: Results demonstrated that first-line treatment of patients with advanced non-small cell lung cancer and high programmed cell death ligand-1 expression who used Roche's Tecentriq monotherapy resulted in improved overall survival compared with platinum-based chemotherapies.
1 - 1 of 1
Showing 20 items per page